Press Releases (Page 349)
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fate Therapeutics Inc. (FATE) Investors and Encourages Investors to Contact the Firm Before March 22, 2023
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Fate Therapeutics, Inc. (“Fate”) (NASDAQ: FATE) securities during the period from April 2, 2020 through January 5, 2023 (the “Class Period”). Investors have until March 22, 2023 to apply to the Court to be... ❯❯❯
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Invivyd, Inc. (IVVD) Investors and Encourages Investors to Contact the Firm Before April 3, 2023
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) securities during the period from November 29, 2021 through December 14, 2021 (the “Class Period”). Investors have until... ❯❯❯
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Argo Blockchain plc (ARBK) Investors and Encourages Investors to Contact the Firm Before March 27, 2023
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Argo Blockchain plc (“Argo” or the “Company”) (NASDAQ: ARBK) securities between September 23, 2021 through October 10, 2022 (the “Class Period”). Investors have until March 27, 2023 to apply to the Court to... ❯❯❯
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Bioventus Inc. (BVS) Investors and Encourages Investors to Contact the Firm Before March 13, 2023
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of North Carolina on behalf of those who acquired Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) securities during the period from February 11, 2021 through November 21, 2022 (the “Class Period”), including investors that purchased... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioLineRx, Enovix, Southwest Airlines, and Y-mAbs and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioLineRx Ltd. (NASDAQ: BLRX), Enovix Corporation (NASDAQ: ENVX), Southwest Airlines Co. (NYSE: LUV), and Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iris, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Iris Energy Limited (NASDAQ: IREN), Twist Bioscience Corp (NASDAQ: TWST), Sunlight Financial Holdings, Inc. (NYSE: SUNL), and Gaia, Inc. (NASDAQ: GAIA). Stockholders have until the deadlines below to petition the court to... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, IBM, and FATE and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bioventus Inc. (NASDAQ: BVS), ESS Tech, Inc. (NYSE: GWH, GWH.WT), International Business Machines Corporation (NYSE: IBM), and Fate Therapeutics, Inc. (NASDAQ: FATE). Stockholders have until the deadlines below to petition... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sotera, Argo, National Vision, and RYVYL and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sotera Health Co. (NASDAQ: SHC), Argo Blockchain Plc, Inc. (NASDAQ: ARBK), National Vision Holdings, Inc. (NASDAQ: EYE), and RYVYL Inc. (NASDAQ: RVYL). Stockholders have until the deadlines below to petition the court to... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tattooed Chef, Daktronics, Gaotu, and Avaya and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Tattooed Chef, Inc. (NASDAQ: TTCF), Daktronics, Inc. (NASDAQ: DAKT), Gaotu Techedu Inc. (NYSE: GOTU), and Avaya Holdings Corp. (NYSE: AVYA, OTCMKTS: AVYAW). Stockholders have until the deadlines below to petition the court to... ❯❯❯
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of Progyny stockholders. Our investigation concerns whether Progyny has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the... ❯❯❯